New blood marker reduces the risk of a false diagnosis of Alzheimer’s disease
Peer-Reviewed Publication
Updates every hour. Last Updated: 16-Jun-2026 00:16 ET (16-Jun-2026 04:16 GMT/UTC)
New blood tests for diagnosing Alzheimer’s disease are making early diagnosis increasingly feasible. However, the fact that the markers being measured change long before any symptoms develop represents a challenge. Research led by Lund University in Sweden shows that a previously unused blood marker, when combined with those markers already in use, can significantly reduce the risk of misleading diagnoses.
Fathers in Sweden are less likely to receive a psychiatric diagnosis during their partner’s pregnancy and in the months following the birth of their child. However, diagnoses of depression and stress-related disorders increase a year later, according to a new study published in JAMA Network Open by researchers at Karolinska Institutet in Sweden and Sichuan University in China.